Daniel Clark
Stock Analyst at Leerink Partners
(2.62)
# 1,964
Out of 5,182 analysts
8
Total ratings
66.67%
Success rate
20.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health | Maintains: Outperform | $26 → $30 | $23.86 | +25.73% | 3 | Feb 24, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $574.00 | +4.53% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $120.08 | +29.08% | 2 | Jul 17, 2025 |
Elanco Animal Health
Feb 24, 2026
Maintains: Outperform
Price Target: $26 → $30
Current: $23.86
Upside: +25.73%
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $574.00
Upside: +4.53%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $120.08
Upside: +29.08%